A novel stress-based intervention reduces cigarette use in non-treatment seeking smokers

Alexandra Barnabe, Karine Gamache, João Vitor Paes de Camargo, Erin Allen-Flanagan, Mathilde Rioux, Jens Pruessner, Marco Leyton, Karim Nader, Alexandra Barnabe, Karine Gamache, João Vitor Paes de Camargo, Erin Allen-Flanagan, Mathilde Rioux, Jens Pruessner, Marco Leyton, Karim Nader

Abstract

Tobacco use is the leading cause of preventable mortality worldwide. Since current smoking cessation aids show only modest efficacy, new interventions are needed. Given the evidence that stress is a potent trigger for smoking, the present randomized clinical trial tested whether stress could augment the effects of a memory updating (retrieval-extinction) intervention. Non-treatment seeking smokers (n = 76) were assigned to one of four conditions composed of either a stressful or non-stressful psychosocial challenge followed by either smoking or neutral cues. Ten minutes after this manipulation, all underwent a 60-minute extinction procedure during which they viewed smoking-related videos and images and manipulated smoking paraphernalia. Compared to participants who were not exposed to the laboratory stressor, the stressor-exposed groups exhibited greater psychophysiological responses during their intervention and greater decreases in cigarette use at two- and six-weeks follow-up independent of smoking cue exposure. Together, these findings suggest that the ability of stress to activate cigarette seeking processes can be exploited to decrease cigarette use. With replication, the stress-based intervention could become a novel strategy for decreasing cigarette use in non-treatment seeking smokers.Clinicaltrials.gov identifier: NCT04843969.

Conflict of interest statement

The authors declare no competing interests.

© 2022. The Author(s).

Figures

Fig. 1. Experimental design and timeline.
Fig. 1. Experimental design and timeline.
During the initial assessment and test sessions 1, 2 and 3, a novel smoking-related video was shown to participants. Physiological measures (heart rate (HR) and skin conductance (SC)) were collected prior to and during the last minute of each video presentation. During these same visits, blood pressure (BP) and self-reported cigarette craving and urge to smoke scores were collected pre- and post-video. On the day of the behavioral intervention, baseline physiological measures (HR, SC, and BP) and self-report data were gathered, followed by one of four conditions (phase 1): stress task and smoking cue, stress task and neutral cue, non-stressful task and smoking cue, or non-stressful task and neutral cue. Physiological and craving measures were collected and followed by a 10-minute break. All participants then went through the extinction protocol (phase 2) consisting of additional smoking videos, smoking images, and the manipulation of smoking-related paraphernalia. Immediately after phase 2, physiological and craving measures were gathered again.
Fig. 2. CONSORT Flow Diagram.
Fig. 2. CONSORT Flow Diagram.
Reasons for withdrawal after randomization included reduction or cessation in cigarette use prior to the intervention, misreporting cigarette use, and a participant having dyscalculia. Scheduling conflicts or time constraints were the primary reasons why some participants declined to participate.
Fig. 3. The stress task-induced psychophysiological and…
Fig. 3. The stress task-induced psychophysiological and craving responses during the behavioral intervention.
During phase 1 (A), participants exposed to the stress task exhibited larger increases in physiological (SC and systolic BP) and craving measures (QSU-Brief and TCQ-SF scores). During phase 2 (B), physiological measures did not significantly differ between groups, but participants previously exposed to the control task exhibited greater smoking cue-induced craving responses (QSU-Brief). BP: blood pressure; SC: skin conductance; TCQ-SF: Tobacco Craving Questionnaire – Short Form; QSU-Brief: Questionnaire on Smoking Urges – Brief. EMM: estimated marginal mean; SEM standard error of the mean. *P < 0.05, ***P < 0.001.
Fig. 4. The stress-based memory intervention led…
Fig. 4. The stress-based memory intervention led to decreased cigarette use at follow-up.
A Participants in the stress-based intervention significantly decreased their average daily cigarette use from baseline to the tests 2 and 3 (two and six weeks after the intervention, respectively). B Cigarette use in the stress group participants decreased by 14% at two weeks (test 2) and by 26% at six weeks (test 3), while the control group showed decreases of 9% and 10%, respectively. EMM: estimated marginal mean; SEM: standard error of the mean. In the stress group: ***P ≤ 0.001 compared to baseline, #P < 0.05 compared to test 2.

References

    1. Centers for Disease Control and Prevention. Smoking & Tobacco Use. 2020. . Accessed 23 April 2021.
    1. Villanti AC, Bover Manderski MT, Gundersen DA, Steinberg MB, Delnevo CD. Reasons to quit and barriers to quitting smoking in US young adults. Fam Pr. 2016;33:133–9. doi: 10.1093/fampra/cmv103.
    1. Twyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: A systematic review of the qualitative and quantitative literature. BMJ Open. 2014;4:1–15.. doi: 10.1136/bmjopen-2014-006414.
    1. Hughes JR. Smokers’ beliefs about the inability to stop smoking. Addict Behav. 2009;34:1005–9. doi: 10.1016/j.addbeh.2009.06.013.
    1. Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: Results from the National Health Interview Survey, 2000. Am J Prev. 2005;28:119–22. doi: 10.1016/j.amepre.2004.09.007.
    1. Jiloha R. Pharmacotherapy of smoking cessation. Indian J Psychiatry. 2014;56:87–95. doi: 10.4103/0019-5545.124726.
    1. Piasecki TM. Relapse to smoking. Clin Psychol Rev. 2006;26:196–215. doi: 10.1016/j.cpr.2005.11.007.
    1. Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A. Smokers deprived of cigarettes for 72 h: Effect of nicotine patches on craving and withdrawal. Psychopharmacology. 2002;164:177–87. doi: 10.1007/s00213-002-1176-1.
    1. Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH. Cue-provoked craving and nicotine replacement therapy in smoking cessation. J Consult Clin Psychol. 2004;72:1136–43. doi: 10.1037/0022-006X.72.6.1136.
    1. Gross B, Brose L, Schumann A, Sabina U, Christian M, Henry V, et al. Reasons for not using smoking cessation aids. BMC Public Health. 2008;8:1–9. doi: 10.1186/1471-2458-8-129.
    1. Rosenthal L, Carroll-Scott A, Earnshaw VA, Naa S, O’Malley SS, Alycia S, et al. Targeting cessation: Understanding barriers and motivations to quitting among urban adult daily tobacco smokers. Addict Behav. 2013;38:1639–42. doi: 10.1016/j.addbeh.2012.09.016.
    1. Niaura RS, Rohsenow DJ, Binkoff JA, Monti PM, Pedraza M, Abrams DB. Relevance of cue reactivity to understanding alcohol and smoking relapse. J Abnorm Psychol. 1988;97:133–52. doi: 10.1037/0021-843X.97.2.133.
    1. Abrams DB, Monti PM, Carey KB, Pinto RP, Jacobus SI. Reactivity to smoking cues and relapse: Two studies of discriminant validity. Behav Res Ther. 1988;26:225–33. doi: 10.1016/0005-7967(88)90003-4.
    1. l’Absi M, Hatsukami D, Davis GL. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology. 2005;181:107–17. doi: 10.1007/s00213-005-2225-3.
    1. Baker TB, Brandon TH, Chassin L. Motivational influences on cigarette smoking. Annu Rev Psychol. 2004;55:463–91. doi: 10.1146/annurev.psych.55.090902.142054.
    1. Brandon TH. Negative affect as motivation to smoke. Curr Dir Psychol Sci. 1994;3:33–37. doi: 10.1111/1467-8721.ep10769919.
    1. Pomerleau CS, Pomerleau OF. The effects of a psychological stressor on cigarette smoking and subsequent behavioral and physiological responses. Psychophysiology. 1987;24:278–85. doi: 10.1111/j.1469-8986.1987.tb00295.x.
    1. Rose JE, Ananda S, Jarvik ME. Cigarette smoking during anxiety-provoking and monotonous tasks. Addict Behav. 1983;8:353–9. doi: 10.1016/0306-4603(83)90035-7.
    1. Slopen N, Kontos EZ, Ryff CD, Ayanian JZ, Albert MA, Williams DR. Psychosocial stress and cigarette smoking persistence, cessation, and relapse over 9–10 years: A prospective study of middle-aged adults in the United States. Cancer Causes Control. 2013;24:1849–63. doi: 10.1007/s10552-013-0262-5.
    1. Eikelboom R, Stewart J. Conditioning of drug-induced physiological responses. Psychol Rev. 1982;89:507–28. doi: 10.1037/0033-295X.89.5.507.
    1. Björkstrand J, Agren T, Åhs F, Andreas F, Elna-Marie L, Olof H, et al. Think twice, it’s all right: Long lasting effects of disrupted reconsolidation on brain and behavior in human long-term fear. Behav Brain Res. 2017;324:125–9. doi: 10.1016/j.bbr.2017.02.016.
    1. Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res. 2008;42:503–6. doi: 10.1016/j.jpsychires.2007.05.006.
    1. Schiller D, Monfils M-H, Raio CM, Johnson DC, LeDoux JE, Phelps EA. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature. 2010;463:49–53. doi: 10.1038/nature08637.
    1. Soeter M, Kindt M. An abrupt transformation of phobic behavior after a post-retrieval amnesic agent. Biol Psychiatry. 2015;78:880–6. doi: 10.1016/j.biopsych.2015.04.006.
    1. Telch MJ, York J, Lancaster CL, Monfils MH. Use of a brief fear memory reactivation procedure for enhancing exposure therapy. Clin Psychol Sci. 2017;5:367–78. doi: 10.1177/2167702617690151.
    1. Lee JL, Nader K, Schiller D. An update on memory reconsolidation updating. Trends Cogn Sci. 2017;21:531–45. doi: 10.1016/j.tics.2017.04.006.
    1. Germeroth LJ, Carpenter MJ, Baker NL, Froeliger B, LaRowe SD, Saladin ME. Effect of a brief memory updating intervention on smoking behavior: A randomized clinical trial. JAMA Psychiatry. 2017;74:214–23. doi: 10.1001/jamapsychiatry.2016.3148.
    1. Marsden J, Goetz C, Meynen T, Luke M, Garry S, Brian E, et al. Memory-focused cognitive therapy for cocaine use disorder: Theory, procedures and preliminary evidence from an external pilot randomised controlled trial. EBioMedicine. 2018;29:177–89. doi: 10.1016/j.ebiom.2018.01.039.
    1. Xue Y-X, Luo Y-X, Wu P, Hai-Shui S, Li-Fen X, Chen C, et al. A memory retrieval-extinction procedure to prevent drug craving and relapse. Science. 2012;336:241–5. doi: 10.1126/science.1215070.
    1. Childs E, de Wit H. Effects of acute psychosocial stress on cigarette craving and smoking. Nicotine Tob Res. 2010;12:449–53. doi: 10.1093/ntr/ntp214.
    1. Buchmann A, Laucht M, Schmid B, Wiedemann K, Mann K, Zimmermann U. Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers. J Psychopharmacol (Oxf) 2008;24:247–55. doi: 10.1177/0269881108095716.
    1. Nakajima M, Lemieux AM, Fiecas M, Soujanya C, Hillol S, Nazir S, et al. Using novel mobile sensors to assess stress and smoking lapse. Int J Psychophysiol. 2020;158:411–8. doi: 10.1016/j.ijpsycho.2020.11.005.
    1. Zhao L-Y, Shi J, Zhang X-L, David HE, Xiang-Yang Z, Yu L, et al. Stress enhances retrieval of drug-related memories in abstinent heroin addicts. Neuropsychopharmacology. 2010;35:720–6. doi: 10.1038/npp.2009.179.
    1. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine Tob Res. 2011;14:75–78. doi: 10.1093/ntr/ntr137.
    1. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerström test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119–27. doi: 10.1111/j.1360-0443.1991.tb01879.x.
    1. Bentz D, Michael T, Wilhelm FH, Francina RH, Sabrina K, von Rohr IRR, et al. Influence of stress on fear memory processes in an aversive differential conditioning paradigm in humans. Psychoneuroendocrinology. 2013;38:1186–97. doi: 10.1016/j.psyneuen.2012.12.018.
    1. Sheehan D, Lecrubier Y, Sheehan KH, Janavs J, Weiller E, Keskiner A, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry. 1997;12:232–41. doi: 10.1016/S0924-9338(97)83297-X.
    1. Karelitz JL, Michael VC, Perkins KA. Analysis of agreement between expired-air carbon monoxide monitors. J Smok Cessat. 2017;12:105–12. doi: 10.1017/jsc.2015.18.
    1. Perkins KA, Karelitz JL, Jao NC. Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine Tob. 2013;15:978–82. doi: 10.1093/ntr/nts205.
    1. Biener L, Abrams DB. The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991;10:360–5. doi: 10.1037/0278-6133.10.5.360.
    1. Etter J-F. A self-administered questionnaire to measure cigarette withdrawal symptoms: The Cigarette Withdrawal Scale. Nicotine Tob Res. 2005;7:47–57. doi: 10.1080/14622200412331328501.
    1. Heishman SJ, Singleton EG, Pickworth WB. Reliability and validity of a Short Form of the Tobacco Craving Questionnaire. Nicotine Tob Res. 2008;10:643–51. doi: 10.1080/14622200801908174.
    1. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3:7–16. doi: 10.1080/14622200020032051.
    1. Dedovic K, Renwick R, Mahani NK, Engert V, Lupien SJ, Pruessner JC. The Montreal Imaging Stress Task: Using functional imaging to investigate the effects of perceiving and processing psychosocial stress in the human brain. J Psychiatry Neurosci. 2005;30:319–25.
    1. Betts JM, Dowd AN, Forney M, Hetelekides E, Tffany ST. A meta-analysis of cue reactivity in tobacco cigarette smokers. Nicotine Tob Res. 2021;23:249–58. doi: 10.1093/ntr/ntaa147.
    1. Saladin ME, Gray KM, Carpenter MJ, LaRowe SD, DeSantis SM, Upadhyaya HP. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict. 2012;21:210–20. doi: 10.1111/j.1521-0391.2012.00232.x.
    1. Sayette MA, Dimoff JD. In search of anticipatory cigarette cravings: The impact of perceived smoking opportunity and motivation to seek treatment. Psychol Addict Behav. 2016;30:277–86. doi: 10.1037/adb0000177.
    1. Dagher A, Tannenbaum B, Hayashi T, Pruessner JC, McBride D. An acute psychosocial stress enhances the neural response to smoking cues. Brain Res. 2009;1293:40–48. doi: 10.1016/j.brainres.2009.07.048.
    1. Rosenberg H. Clinical and laboratory assessment of the subjective experience of drug craving. Clin Psychol Rev. 2009;29:519–34. doi: 10.1016/j.cpr.2009.06.002.
    1. Venugopalan VV, Casey KF, O’Hara C, O’Loughlin J, Benkelfat C, Fellows LK, et al. Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction. Neuropsychopharmacology. 2011;36:2469–76. doi: 10.1038/npp.2011.135.
    1. Lowe MR, Green L, Kurtz SM, Ashenberg ZS, Fisher EB., Jr Self-initiated, cue extinction, and covert sensitization procedures in smoking cessation. J Behav Med. 1980;3:357–72. doi: 10.1007/BF00845290.
    1. Götestam KG, Melin L. An experimental study of covert extinction on smoking cessation. Addict Behav. 1983;8:27–31. doi: 10.1016/0306-4603(83)90052-7.
    1. Conklin CA, Tiffany ST. Applying extinction research and theory to cue‐exposure addiction treatments. Addiction. 2002;97:155–67. doi: 10.1046/j.1360-0443.2002.00014.x.
    1. Niaura R, Abrams DB, Shadel WG, Rohsenow DJ, Monti PM, Sirota AD. Cue exposure treatment for smoking relapse prevention: A controlled clinical trial. Addiction. 1999;94:685–95. doi: 10.1046/j.1360-0443.1999.9456856.x.
    1. Pericot-Valverde I, Secades-Villa R, Gutiérrez-Maldonado J. A randomized clinical trial of cue exposure treatment through virtual reality for smoking cessation. J Subst Abus Treat. 2019;96:26–32. doi: 10.1016/j.jsat.2018.10.003.
    1. Brandon TH, Zelman DC, Baker TB. Effects of maintenance sessions on smoking relapse: Delaying the inevitable? J Consulting Clin Psychol. 1987;55:780–7822.. doi: 10.1037/0022-006X.55.5.780.
    1. de Quervain DJF, Bentz D, Michael TT, Bolt OC, Wiederhold BK, Margraf J, et al. Glucocorticoids enhance extinction-based psychotherapy. Proc Nat Acad Sci. 2011;108:6621–5. doi: 10.1073/pnas.1018214108.
    1. Siegmund A, Köester L, Meves AM, Plag J, Stoy M, Ströhle A. Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia. J Psychiatr Res. 2011;45:339–46. doi: 10.1016/j.jpsychires.2010.07.002.
    1. Soravia LM, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U, et al. Glucocorticoids reduce phobic fear in humans. Proc Nat Acad Sci. 2006;103:5585–90. doi: 10.1073/pnas.0509184103.
    1. Meir Drexler S, Merz CJ, Wolf OT. Preextinction stress prevents context-related renewal of fear. Behav Ther. 2018;49:1008–19. doi: 10.1016/j.beth.2018.03.001.
    1. Meuret AE, Trueba AF, Abelson JL, Liberzon I, Auchus R, Bhaskara L, et al. High cortisol awakening response and cortisol levels moderate exposure-based psychotherapy success. Psychoneuroendocrinology. 2015;51:331–40. doi: 10.1016/j.psyneuen.2014.10.008.
    1. Yehuda R, Bierer LM, Pratchett LC, Lehrner A, Koch EC, Van Manen JA, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015;51:589–97. doi: 10.1016/j.psyneuen.2014.08.004.
    1. Soravia LM, Moggi F, de Quervain DJF. Effects of cortisol administration on craving during in vivo exposure in patients with alcohol use disorder. Transl Psychiatry. 2021;11:1–9. doi: 10.1038/s41398-020-01180-y.
    1. Zandonai T, Benvegnù G, Tommasi F, Ferrandi E, Libener E, Ferraro S, et al. A virtual reality study on postretrieval extinction of smoking memory reconsolidation in smokers. J Subs Abus Treat. 2021;125:108317. doi: 10.1016/j.jsat.2021.108317.
    1. Björkstrand J, Agren T, Åhs F, Frick A, Larsson EM, Hjorth O, et al. Disrupting reconsolidation attenuates long-term fear memory in the human amygdala and facilitates approach behavior. Curr Biol. 2016;26:2690–5. doi: 10.1016/j.cub.2016.08.022.
    1. de Quervain DJF, Margraf J. Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: A novel therapeutic approach. Eur J Pharm. 2008;583:365–71. doi: 10.1016/j.ejphar.2007.11.068.

Source: PubMed

3
Subscribe